CoChat

Explainable artificial intelligence in skin cancer recognition: A systematic review

Open access
Hauser, Katja, Kurz, Alexander, Haggenmüller, Sarah, Maron, Roman C., von Kalle, Christof, Utikal, Jochen S., Meier, Friedegund, Hobelsberger, Sarah, Gellrich, Frank F., Sergon, Mildred, Hauschild, Axel, French, Lars E., Heinzerling, Lucie, Schlager, Justin G., Ghoreschi, Kamran, Schlaak, Max, Hilke, Franz J., Poch, Gabriela, Kutzner, Heinz, Berking, Carola, Heppt, Markus V., Erdmann, Michael, Haferkamp, Sebastian, Schadendorf, Dirk, Sondermann, Wiebke, Goebeler, Matthias, Schilling, Bastian, Kather, Jakob N., Fröhling, Stefan, Lipka, Daniel B., Hekler, Achim, Krieghoff-Henning, Eva, Brinker, Titus J. · 2022 · European Journal of Cancer
Cited by 175

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Due to their ability to solve complex problems, deep neural networks (DNNs) are becoming increasingly popular in medical applications. However, decision-making by such algorithms is essentially a black-box process that renders it difficult for physicians to judge whether the decisions are reliable. The use of explainable artificial intelligence (XAI) is often suggested as a solution to this problem. We investigate how XAI is used for skin cancer detection: how is it used during the development of new DNNs? What kinds of visualisations are commonly used? Are there systematic evaluations of XAI with dermatologists or dermatopathologists? METHODS: Google Scholar, PubMed, IEEE Explore, Science Direct and Scopus were searched for peer-reviewed studies published between January 2017 and October 2021 applying XAI to dermatological images: the search terms histopathological image, whole-slide image, clinical image, dermoscopic image, skin, dermatology, explainable, interpretable and XAI were used in various combinations. Only studies concerned with skin cancer were included. RESULTS: 37 publications fulfilled our inclusion criteria. Most studies (19/37) simply applied existing XAI methods to their classifier to interpret its decision-making. Some studies (4/37) proposed new XAI methods or improved upon existing techniques. 14/37 studies addressed specific questions such as bias detection and impact of XAI on man-machine-interactions. However, only three of them evaluated the performance and confidence of humans using CAD systems with XAI. CONCLUSION: XAI is commonly applied during the development of DNNs for skin cancer detection. However, a systematic and rigorous evaluation of its usefulness in this scenario is lacking.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ejca.2022.02.025

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 37 references

Cited by

Metadata

Authors
Hauser, K., Kurz, A., Haggenmüller, S., Maron, R. C., von Kalle, C., Utikal, J. S., Meier, F., Hobelsberger, S., Gellrich, F. F., Sergon, M., Hauschild, A., French, L. E., Heinzerling, L., Schlager, J. G., Ghoreschi, K., Schlaak, M., Hilke, F. J., Poch, G., Kutzner, H., Berking, C., Heppt, M. V., Erdmann, M., Haferkamp, S., Schadendorf, D., Sondermann, W., Goebeler, M., Schilling, B., Kather, J. N., Fröhling, S., Lipka, D. B., Hekler, A., Krieghoff-Henning, E., & Brinker, T. J.
Venue
European Journal of Cancer
Publisher
Elsevier BV
Published
2022-05
Volume
167
Pages
54-69
ISSN
0959-8049 (ISSN-L)
OpenAlex
W4225310474
Cited by
175
References
37
FWCI
2.86
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.